Neumentum

OverviewSuggest Edit

Neumentum is a pain and neurology specialty pharmaceutical company that develops and commercializes novel non-opioid pain products.

TypePrivate
Founded2017
HQPalo Alto, US
Websiteneumentum.com

Latest Updates

Employees (est.) (Oct 2020)7(+17%)
Cybersecurity ratingAMore

Key People/Management at Neumentum

R. Scott Shively

R. Scott Shively

Chief Executive Officer, Director
Ilona Steigerwald

Ilona Steigerwald

Chief Medical Officer
Salma Lemtouni

Salma Lemtouni

VP – Regulatory Affairs
Robert B. Raffa

Robert B. Raffa

Chief Scientific Officer
Christine Mikail

Christine Mikail

Chief Business Officer
Sarah Howlett Faust

Sarah Howlett Faust

Chief Commercial Officer
Show more

Neumentum Office Locations

Neumentum has an office in Palo Alto
Palo Alto, US (HQ)
252 Colorado Ave
Show all (1)

Neumentum Financials and Metrics

Summary Metrics

Founding Date

2017

Neumentum total Funding

$6 m

Neumentum latest funding size

$6 m

Time since last funding

3 years ago

Neumentum investors

Neumentum's latest funding round in December 2017 was reported to be $6 m. In total, Neumentum has raised $6 m
Show all financial metrics

Neumentum Cybersecurity Score

Cybersecurity ratingPremium dataset

A

90/100

SecurityScorecard logo

Neumentum Online and Social Media Presence

Embed Graph

Neumentum News and Updates

Neumentum Announces Dosing of Patients in Phase I Study Evaluating Its Lead Product Candidate, NTM-001, a Non-Opioid in Development for the Management of Moderately Severe Acute Pain

PALO ALTO, Calif., Sept. 6, 2018 /PRNewswire/ -- Neumentum, a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced it completed dosing the first cohort of patients in its phase I study of NTM-001 (pre-mixed bag ketorolac for...

Neumentum Blogs

NEUMENTUM, INC. CHIEF EXECUTIVE OFFICER SCOTT SHIVELY TO PRESENT AT BIO DIGITAL CONFERENCE

PALO ALTO, Calif., June 5, 2020 – Neumentum, Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott Shively, Chief Executive Officer, has posted a presentation for digital viewing for the BIO Digital Conference scheduled for Ju…

NEUMENTUM, INC. NOMINATED FOR TWO CITELINE AWARDS

Neumentum, Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that it has been nominated for two Informa Pharma Intelligence Citeline Awards including the Most Successful Early Stage Research and Clinical Trial Result of the Year cate…

Continuous Ketorolac Infusion Formulation Predicted to Provide Rapid-Onset Pain Relief

There is strong evidence that a continuous infusion formulation of ketorolac (NTM-001, Neumentum) achieves a fast onset of effective analgesia that is maintained at a stable level over 24 hours, based on initial results of a phase 1 trial and a PubMed literature review of infusion trials in a variet…

Neumentum, Inc. Chief Executive Officer, Scott Shively, To Present at BIO CEO and Investor Conference in New York

Scott Shively, Chief Executive Officer, will present at the BIO CEO and Investor Conference held February, 10 – 11, 2020 at the Marriot Marquis in New York City The post Neumentum, Inc. Chief Executive Officer, Scott Shively, To Present at BIO CEO and Investor Conference in New York appeared first …

Neumentum, Inc. Chief Executive Officer, Scott Shively, To Present at 2020 Biotech Showcase in San Francisco, CA

Neumentum, Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Scott Shively, Chief Executive Officer, will present at the 2020 Biotech Showcase being held January 13-15, 2020 in San Francisco, CA. The post Neumentum, Inc. Chief E…

Neumentum, Inc. Executive Chairman, Joseph Pergolizzi, Jr., M.D. and Chief Scientific Officer, Robert Raffa, Ph.D. To Present at 2019 Pain Summit in Philadelphia, PA

Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today announced that Joseph Pergolizzi, Jr., M.D. and Robert Raffa, Ph.D., will both present keynote speeches at the upcoming Pain Summit being held November 19-20th in Philadelphia, PA. Th…
Show more

Neumentum Frequently Asked Questions

  • When was Neumentum founded?

    Neumentum was founded in 2017.

  • Who are Neumentum key executives?

    Neumentum's key executives are R. Scott Shively, Ilona Steigerwald and Salma Lemtouni.

  • How many employees does Neumentum have?

    Neumentum has 7 employees.

  • Who are Neumentum competitors?

    Competitors of Neumentum include The Feel Good Lab, Integrated Prescription Management and OutcomesMTM.

  • Where is Neumentum headquarters?

    Neumentum headquarters is located at 252 Colorado Ave, Palo Alto.

  • Where are Neumentum offices?

    Neumentum has an office in Palo Alto.

  • How many offices does Neumentum have?

    Neumentum has 1 office.